Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Non-invasive method for measuring bone mineral density].

Christian Roux1

  • 1Centre d'Evaluation des Maladies Osseuses, Institut de Rhumatologie, Hôpital Cochin, 27, rue du Faubourg Saint-Jacques, 75014 Paris, France. christian.roux@cch.ap-hop-paris.fr

Medecine Sciences : M/S
|July 3, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rare disease care pathways profile in France: leveraging hospital big data to characterize natural history in osteogenesis imperfecta.

JBMR plus·2026
Same author

Long-Term Effects of Rheumatoid Arthritis Treatments on Bone Mineral Density: 8-Year-Follow-Up Data from Real-World Practice.

Journal of clinical medicine·2026
Same author

Marked regression of calcinosis with canakinumab in hyperphosphatemic familial tumoral calcinosis.

JBMR plus·2026
Same author

Impact of regulatory events on JAK inhibitor prescribing in rheumatoid arthritis: Insights from the French MAJIK Registry.

Joint bone spine·2025
Same author

Opportunistic screening for osteoporosis and vertebral fracture using CT attenuation from 18F-fluorocholine PET/CT in patients with prostate cancer.

RMD open·2025
Same author

Cartilage turnover, but not novel synovial collagen marker, is associated with joint damage progression in osteoarthritis patients.

Rheumatology (Oxford, England)·2025
Same journal

[CREPT: An ally of immunotherapy for the fight against non-small-cell lung cancers].

Medecine sciences : M/S·2026
Same journal

[A new regulatory mechanism of HIF-1α: the ROS-ATM-CHK2 axis at the core of tumor angiogenesis].

Medecine sciences : M/S·2026
Same journal

[Vibrio-host interactions: from the environmental niche to virulence].

Medecine sciences : M/S·2026
Same journal

[RcsF, hyperconnected sentinel of the bacterial envelope].

Medecine sciences : M/S·2026
Same journal

[Single-cell RNA-sequencing: shattering the clone myth].

Medecine sciences : M/S·2026
Same journal

[No, Physarum blobs do not have 720 sexes!]

Medecine sciences : M/S·2026
See all related articles

Dual energy X-ray absorptiometry measures bone mineral density (BMD) to define osteoporosis. BMD, age, and hormonal factors predict fracture risk, guiding therapeutic decisions.

Area of Science:

  • Osteoporosis Research
  • Bone Health Diagnostics

Context:

  • Osteoporosis diagnosis relies on bone mineral density (BMD) measurements.
  • Dual energy X-ray absorptiometry (DXA) is the standard method for BMD assessment.

Purpose:

  • To highlight the role of BMD measurement in defining osteoporosis.
  • To explain the relationship between BMD, risk factors, and fracture incidence.

Summary:

  • DXA offers sufficient accuracy, precision, and sensitivity for clinical osteoporosis diagnosis.
  • Prospective studies demonstrate a clear risk gradient: decreased BMD (due to aging, hormonal changes) correlates with increased fracture incidence.
  • Therapeutic strategies integrate both BMD values and clinical risk factors.

Impact:

Related Experiment Videos

  • Establishes DXA as a reliable tool for osteoporosis diagnosis.
  • Informs clinical decision-making by linking BMD and fracture risk.
  • Supports personalized treatment approaches for osteoporosis management.